scholarly article | Q13442814 |
P2093 | author name string | Paul Kwo | |
Deepti Dronamraju | |||
P2860 | cites work | An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection | Q92319689 |
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis | Q92720274 | ||
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study | Q96342937 | ||
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment | Q98776756 | ||
The Current State of Peritoneal Dialysis | Q30243902 | ||
Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan | Q34980383 | ||
Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? | Q38032025 | ||
Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis | Q38551250 | ||
Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease | Q40117313 | ||
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study | Q40957442 | ||
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment. | Q41918943 | ||
Hepatitis C infection is very rarely treated among hemodialysis patients. | Q42257638 | ||
Direct-Acting Antiviral Sustained Virologic Response: Impact on Mortality in Patients without Advanced Liver Disease | Q47644014 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | chronic renal insufficiency | Q736715 |
peritoneal dialysis | Q1756474 | ||
P577 | publication date | 2020-09-24 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis |
Search more.